One of the first things many women encounter when beginning to explore fertility after 35 is the concept of “ovarian reserve” — a term used to describe the quantity and, to some degree, the quality of eggs remaining in the ovaries. As fertility awareness has grown, tests that assess ovarian reserve have become more widely known and more frequently offered. Understanding what these tests measure, what they can and cannot tell you, and how to interpret results in context can help reduce some of the anxiety that often surrounds this topic.
It’s worth stating upfront that ovarian reserve testing is informative but not predictive. A low ovarian reserve marker does not necessarily mean a woman cannot conceive naturally, and a normal result does not guarantee conception. These tests offer useful data points in a broader fertility picture, but they are best interpreted with the guidance of a reproductive endocrinologist or fertility specialist who can contextualize the numbers against your individual history and goals.
This article explores the most common ovarian reserve tests, what they measure, and what the research says about their predictive value — so you can approach these conversations with your provider better informed.
What Is Ovarian Reserve and Why Does It Matter After 35?
Women are born with all the eggs they will ever have — approximately one to two million at birth — and this number declines throughout life through a process called atresia. By puberty, the count has typically fallen to several hundred thousand, and the decline continues throughout the reproductive years. By the mid-30s, the rate of decline accelerates for most women, and the quality of remaining eggs — their chromosomal integrity — also becomes an increasingly important factor in fertility.
According to the American College of Obstetricians and Gynecologists (ACOG), fertility begins to decline more noticeably after age 32 and more significantly after 37. However, these are population-level trends, and individual ovarian reserve varies considerably. Some women at 38 have ovarian reserve comparable to women in their late 20s; others at 34 may have diminished reserve. This is precisely why testing can be useful — it gives individualized information rather than relying solely on age as a proxy.
The Most Common Ovarian Reserve Tests
Anti-Müllerian Hormone (AMH)
AMH is produced by small follicles in the ovaries and is currently the most widely used marker of ovarian reserve. Unlike other hormonal markers, AMH levels are relatively stable throughout the menstrual cycle, which means it can be measured on any cycle day. Higher AMH levels generally suggest a larger pool of remaining follicles; lower levels suggest a smaller pool.
AMH is expressed in ng/mL or pmol/L depending on the lab. “Normal” ranges vary by age and laboratory, which is one reason it’s essential to interpret results with a specialist rather than in isolation. An AMH that appears low for a 28-year-old might be entirely within the expected range for a 38-year-old, and vice versa.
Antral Follicle Count (AFC)
The AFC is measured via transvaginal ultrasound, typically early in the menstrual cycle. The sonographer counts the small, early-stage follicles visible in both ovaries — these “antral follicles” represent eggs that are potentially available for development in that cycle and subsequent cycles. A higher AFC generally correlates with better ovarian reserve.
AFC is considered alongside AMH because they tend to correlate well, and having both measurements can provide a more complete picture. AFC is best performed by an experienced sonographer, as counts can vary depending on equipment and technique.
FSH (Follicle Stimulating Hormone) and Estradiol on Cycle Day 3
A blood test taken on day 2, 3, or 4 of the menstrual cycle measuring FSH and estradiol was the traditional way to assess ovarian reserve before AMH testing became available. Elevated FSH on day 3 suggests the pituitary gland is working harder than usual to stimulate the ovaries — a potential sign of diminished reserve. Estradiol is measured alongside FSH because elevated day-3 estradiol can artificially suppress FSH, making a potentially elevated FSH appear normal.
Day-3 FSH and estradiol are still clinically useful, particularly in conjunction with AMH and AFC, though AMH has generally become the preferred initial screening marker because of its cycle-day independence.
What Ovarian Reserve Tests Cannot Tell You
This is an important nuance: ovarian reserve tests measure egg quantity more than egg quality. A woman can have a relatively high AMH but still experience difficulty conceiving due to chromosomal issues with eggs — a factor that increases with age and is not captured by reserve testing.
Similarly, ovarian reserve tests do not assess the uterine environment, sperm quality, or other anatomical factors that affect fertility. They are one piece of a comprehensive fertility evaluation. A reproductive endocrinologist will typically combine ovarian reserve data with a complete history, pelvic ultrasound, assessment of the fallopian tubes (when relevant), and male factor evaluation before drawing conclusions about a couple’s overall fertility picture.
Another important limitation: AMH is not strongly predictive of natural conception. Research has shown that women with lower AMH levels can and do conceive naturally — the test is more useful in predicting response to ovarian stimulation in IVF than in predicting natural conception chances. For more context on the fertility evaluation process, our article on when to see a fertility specialist after 35 offers additional guidance.
When to Consider Ovarian Reserve Testing
ACOG currently recommends that women who are 35 or older and have been trying to conceive for six months without success consider a fertility evaluation — including ovarian reserve testing. For women 40 and older, some specialists recommend earlier evaluation, even after just a few months of trying.
Some women choose to have ovarian reserve testing proactively — before actively trying to conceive — to inform family planning decisions. This is a personal choice with real value for some women, though it’s worth approaching the results with the understanding that they are data points, not deterministic predictions.
Interpreting Results: A Conversation, Not a Verdict
If your results suggest diminished ovarian reserve, it’s natural to feel distressed. It’s important to resist interpreting any single number as a final verdict on your fertility. Many women with low AMH have gone on to conceive — naturally and through IVF. Conversely, women with normal reserve numbers may still face fertility challenges for unrelated reasons.
A specialist can help you understand what your numbers mean in the context of your age, your partner’s fertility, your reproductive history, and your goals. They can also discuss options — from continuing to try naturally to pursuing IVF, egg freezing, or other paths — based on a personalized assessment.
The emotional dimensions of ovarian reserve testing deserve acknowledgment too. Receiving results that are different from what you hoped can trigger grief, anxiety, and a sense of urgency. These feelings are valid and common, and support — whether from a trusted friend, partner, or mental health professional — can be genuinely helpful. Our article on navigating the emotional aspects of the fertility journey explores this further.
Frequently Asked Questions
Is AMH testing covered by insurance?
Coverage varies widely by insurance plan and location. In many cases, AMH testing ordered as part of a fertility evaluation may be covered when there is a documented diagnosis of infertility, but this is not universal. It’s worth checking with your insurance provider and asking your healthcare provider’s billing team about coverage before testing.
Can I do anything to improve my ovarian reserve?
Ovarian reserve — the number of remaining eggs — cannot be increased, as eggs are not regenerated after birth. However, overall health, including maintaining a healthy weight, avoiding smoking, and managing chronic stress, may support egg quality to some degree. Any specific interventions should be discussed with your specialist.
What is a “normal” AMH level for women over 35?
AMH reference ranges vary by laboratory and are always interpreted in context of age. Generally, AMH between 1.0–3.5 ng/mL is considered within a typical range for women in their mid-to-late 30s, though some labs use different thresholds. Your specialist can explain how your specific result compares to age-matched expectations at their clinic.
Does a low AMH mean I should immediately pursue IVF?
Not necessarily. A reproductive endocrinologist will consider your full clinical picture — including your age, how long you’ve been trying, your partner’s fertility, and your own preferences — before recommending a specific path. Some women with lower AMH conceive naturally or with less intensive interventions. A specialist consultation is the right starting point.
Key Takeaways
- Ovarian reserve tests (AMH, AFC, day-3 FSH/estradiol) measure egg quantity more than quality — they are informative but not definitively predictive of conception chances.
- AMH is the most widely used marker because it’s stable throughout the cycle and correlates well with antral follicle counts.
- A low ovarian reserve result does not mean conception is impossible — many women with diminished reserve conceive naturally or with fertility support.
- ACOG recommends fertility evaluation — including reserve testing — after 6 months of trying for women 35+, and earlier for those 40+.
- Results are best interpreted by a reproductive specialist who can contextualize them against your individual history, goals, and other fertility factors.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual health situations vary significantly. Always consult a qualified healthcare provider before making decisions related to your health, fertility, or pregnancy.
About the Author
Emily Carter is a women’s health writer focused on fertility, pregnancy after 35, and sleep changes in midlife. She writes research-informed, non-alarmist content to help women navigate reproductive and hormonal transitions with clarity and confidence.